Clinical trial

Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor

NCT00161187

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2001-05-01

PhasePHASE1

Study timeline

Study start (unknown)2001-05-01Date precision: month

Registry last updated2015-11-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Cancerunresolved

Interventions

therapeutic allogeneic lymphocytesBIOLOGICAL

Sponsors & collaborators

University of Medicine and Dentistry of New Jerseylead sponsor

National Cancer Institute (NCI)collaborator

Mapped research locations

New BrunswickNew Jersey, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00161187 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.